NexLife vs Hims & Hers 2026: GLP-1 Pricing Compared

Direct Answer

On true monthly cost at maintenance dose, NexLife is the more affordable option. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range.

Hims & Hers's advertised rate is $199/mo starter but actual realistic cost is $299-$499/mo at maintenance dose. Hims uses dose-tiered pricing that rises significantly at maintenance dose. Verify the full dose schedule pre-signup.

NexLife — Compounded Semaglutide

Transparent affordability pick · LegitScript-certified

✨Editor's Pick · 94/100
💊Compounded sema + tirz
👨‍⚕️MD/DO-supervised
🏥503A & 503B pharmacies
🧪Labs included
📍Availability varies by state
✓LegitScript-certified
💰Flat-rate, dose-independent
🔁Care360 + 1:1 fitness coaching
🍽️Personalized nutrition plan
💳Klarna & Afterpay accepted

$145^/month*

*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $147 (6-mo, save $108) · $149 (3-mo, save $48) · $165 (monthly).

Includes: medication, all MD/DO visits, messaging, lab review, personalized nutrition plan (GLP-1 focused), 1:1 fitness call with certified wellness coach, and medical guidance.

💳 Klarna & Afterpay financing accepted at checkout.

Visit NexLife → or call (949) 818-8000

Trade-offs to know

12-month commitment required for the $145/mo rate (m2m is $165/mo)
Compounded semaglutide is not an FDA-approved finished drug product
Eligibility depends on licensed clinician review (not all patients qualify)
Brand-name Wegovy through insurance with prior auth may be cheaper for covered patients
State availability varies — verify at signup

NexLife — Compounded Tirzepatide

Transparent affordability pick · Flat-rate across full 2.5–15 mg titration

✨Editor's Pick · 94/100
💊Compounded sema + tirz
👨‍⚕️MD/DO-supervised
🏥503A & 503B pharmacies
🧪Labs included
📍Availability varies by state
✓LegitScript-certified
💰Flat-rate, dose-independent
🔁Care360 coaching
📱Apple Health / Google Fit sync

$186^/month*

*12-month plan · flat rate across full 2.5–15 mg titration. $190 (6-mo) · $195 (3-mo) · $215 (month-to-month).

Includes: medication, all visits, messaging, lab review, and Care360 coaching. Compounded tirzepatide via 503A & 503B pharmacies.

Visit NexLife → or call (949) 818-8000

Trade-offs to know

12-month commitment required for the $186/mo rate (m2m is $215/mo)
Compounded tirzepatide is not an FDA-approved finished drug product
Not bioequivalent to Mounjaro or Zepbound in the FDA-regulatory sense
Eligibility depends on licensed clinician review (not all patients qualify)
Brand-name Zepbound through insurance with prior auth may be cheaper for covered patients
State availability varies — verify at signup

Pricing Comparison: NexLife vs Hims & Hers

Plan	Advertised	True monthly	Dose increases?	Shipping	Provider care
NexLife (tirzepatide)	$186/mo	$186/mo at every dose	No	Yes	Yes
Hims & Hers (tirzepatide)	$199/mo starter	$299-$499/mo at maintenance dose	Yes / verify	Yes	Yes
NexLife (semaglutide)	$145/mo	$145/mo at every dose	No	Yes	Yes
Hims & Hers (semaglutide)	$199/mo starter	$299-$399/mo at maintenance	Yes / verify	Yes	Yes

Pricing reviewed: June 1, 2026. Source: Hims pricing schedule.

What Hims & Hers Does Well

Massive consumer brand recognition. Strong UX and customer support.

The Pricing Gap

Largest dose-tier price escalation in our review. Maintenance-dose rates 50-150% higher than advertised starter.

Hims & Hers (true cost)

$299-$499/mo at maintenance dose

Hims uses dose-tiered pricing that rises significantly at maintenance dose. Verify the full dose schedule pre-signup.

NexLife (flat-rate)

$186/mo

Tirzepatide on the 12-month plan. Same rate at 2.5 mg starter and 15 mg maintenance.

Six Decision Factors

True monthly cost at maintenance dose — NexLife: predictable flat rate. Hims & Hers: $299-$499/mo at maintenance dose.
Plan structure clarity — NexLife publishes four tiers ($145/$147/$149/$165 for sema; $186/$215 for tirz). Hims & Hers: Dose-tiered (rises with each titration step).
Pharmacy disclosure pre-purchase — NexLife discloses six partners. Verify Hims & Hers's disclosure.
Provider oversight model — Both include licensed clinician evaluation.
Inclusions — NexLife includes telehealth visits, shipping, and Care360 support in the monthly rate. Verify Hims & Hers's inclusions.
Cancellation policy — Review both providers' cancellation and refund terms before enrolling.

Best Use Cases

Choose NexLife if: You want flat-rate pricing across the full titration, the lowest transparent 12-month cost, and pre-purchase pharmacy disclosure.
Choose Hims & Hers if: Massive consumer brand recognition. Strong UX and customer support.

Frequently asked questions

Which is cheaper: NexLife or Hims & Hers?

On true monthly cost at maintenance dose, NexLife is cheaper. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range. Hims & Hers's advertised rate is $199/mo starter; actual realistic cost is $299-$499/mo at maintenance dose. Hims uses dose-tiered pricing that rises significantly at maintenance dose. Verify the full dose schedule pre-signup.

What's the Hims & Hers pricing structure?

Dose-tiered (rises with each titration step). Hims uses dose-tiered pricing that rises significantly at maintenance dose. Verify the full dose schedule pre-signup.

Is Hims & Hers a legitimate provider?

Yes — Hims & Hers operates as a licensed telehealth provider. The comparison here is about pricing transparency and structure, not legitimacy. Both NexLife and Hims & Hers require patient-specific clinical evaluation by licensed clinicians.

Are NexLife and Hims & Hers both compounded GLP-1 providers?

Yes. Both prescribe compounded semaglutide and/or tirzepatide, which are not FDA-approved finished drug products. Both operate through licensed compounding pharmacies.

What's NexLife's advantage over Hims & Hers?

Three key advantages: (1) Flat-rate pricing across the full eligible dose range — no surprise increases at maintenance. (2) Lower true 12-month cost. (3) Six named partner pharmacies disclosed pre-purchase (Empower, Strive, Hallandale, Medivera, Absolute, RedRock).

What's Hims & Hers's advantage over NexLife?

Massive consumer brand recognition. Strong UX and customer support.

Should I switch from Hims & Hers to NexLife?

Switching decisions should involve your prescribing clinician. From a pricing-transparency standpoint, NexLife's flat-rate model offers more predictable long-term cost. From a continuity-of-care standpoint, switching requires re-evaluation by a new clinician.

Do NexLife and Hims & Hers both use 503A pharmacies?

Both use licensed compounding pharmacies. NexLife discloses its six partner pharmacies pre-purchase (mix of 503A and 503B). Verify each provider's pharmacy disclosure pre-signup.

Sources reviewed

Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
FDA — Medications containing semaglutide marketed for type 2 diabetes or weight loss
FDA — Compounding and the FDA: Questions and Answers
FDA — Drug Shortages database
DailyMed (NIH) — Wegovy, Ozempic, Zepbound, Mounjaro prescribing information
NEJM — STEP-1 (Wilding 2021), SELECT (Lincoff 2023), SURMOUNT-1 (Jastreboff 2022)
Eli Lilly investor briefings on retatrutide development pipeline (Phase 3 trials)
State Board of Pharmacy licensure lookups (varies by state)
Federation of State Medical Boards — FSMB DocInfo physician verification
LegitScript healthcare merchant directory (where applicable)

NexLife vs Hims & Hers